Incontinence Solutions from the 3M™ Cavilon™ Professional Skin Care Products Family

TM

for IncontinenceSkin Care

Patients with incontinence are at high risk for skin damage• Skin damage in hospitalized patients has been reported to be as high

as 42.5%, with IAD and pressure ulcers being the most common types of skin injury(1)

• IAD in the intensive care setting has been reported to be as high as 95%(2)

Strengthen your Pressure Ulcer Prevention Program and Avoid Costs Associated with Skin Damage Incontinence is a risk factor in the development of Pressure Ulcers• Moisture on the skin increases friction and friction

is a component of shear which can contribute to pressure ulcer formation

• Pressure ulcers cause patient suffering and increase the costs of health care

• Prevention of avoidable pressure ulcers is a clear indicator of the quality of nursing care

Incontinence often results in Incontinence-Associated Dermatitis (IAD)• Exposure to urine or urine and stool causes

inflammation; resulting skin damage can range from erythema to severe epidermal loss

• IAD results in patient suffering, increases the risk of secondary infection and increases cost

Application of a moisture barrier for protection of at risk skin is recommended in widely recognized pressure ulcer prevention guidelines and IAD best practice documents.(3, 4)

PreventingSkin BreakdownImproves Clinical Outcomes

and Can Save

Budget Dollars

Incontinence

Moisture

Increased Friction

Increased Shear

Increased Risk of PU Formation

3M™ Cavilon™ No Sting Barrier Film: Treatment and Prevention of IAD What is it? Cavilon No Sting Barrier Film is an alcohol-free moisture barrier. It contains unique ingredients called polymers that form a waterproof, protective coating on the skin. It is breathable and transparent allowing for continuous visualization and monitoring of skin. It is flexible and conforms to the skin during movement or position changes.• Helps protects skin from damage due to friction• Does not transfer off and block incontinence briefs or pads(5)

• Fragrance-free, preservative-free and latex-free• Hypoallergenic(6)

• Non-cytotoxic(6)—can be used on intact and damaged skin• Compatible with chlorhexidine gluconate(6)

• Cost-effective(7, 8)

Ask for Cavilon No Sting Barrier FilmCavilon No Sting Barrier Film is like no other moisture barrier 1) Unique Formulation of not one but two polymers:

The additional polymer enables the film to flex with the skin and helps to maintain a continuous protective coating. Other barrier films contain only one polymer and some utilize alcohol as a solvent. With Cavilon No Sting Barrier Film you can be confident that you have an effective barrier and excellent patient comfort.

2) Evidence-based, with over 70 pieces of clinical evidence supporting the efficacy and cost-effectiveness of Cavilon No Sting Barrier Film for multiple clinical uses, including prevention and treatment of IAD.(9) This represents more evidence than any other moisture barrier or barrier film.

Terpolymer + Silicone Homopolymer = Effective Flexible Barrier

PREVENTION

TREATMENT

Use 3M™ Cavilon™ No Sting Barrier Film when skin is:• damaged/broken• intact, but risk of damage is high (e.g. frequent or continuous diarrhea)

Effective

Barriers to Supportyour

and Economical

Prevention and Treatment Efforts

Effective

Barriers to Supportand Economical

Prevention and Treatment Efforts

Ask for Cavilon Durable Barrier CreamCavilon Durable Barrier Cream is like no other barrier cream 1) Unique formulation of 3M polymers and dimethicone for skin protection, as well as skin conditioning

ingredients for moisturization:

Unlike typical products used for IAD prevention, Cavilon Durable Barrier Cream is both durable and concentrated. This means it lasts longer, you use less than typical creams or ointments, and it allows adhesives to adhere!

2) Evidence-based, with over 16 pieces of clinical evidence supporting the efficacy of Cavilon Durable Barrier Cream.(11) With Cavilon Durable Barrier Cream you can be confident that you are providing evidence-based care.

Polymers + Dimethicone = Long Lasting Protection

PREVENTION

Use 3M™ Cavilon™ Durable Barrier Cream when skin is:• intact and normal in color• intact with light/mild erythema

3M™ Cavilon™ Durable Barrier Cream: Prevention of IAD What is it? Cavilon Durable Barrier Cream is a unique, moisturizing barrier cream formulated with 3M polymers. It is breathable and vanishes into the skin. This prevents clogging of briefs(10) and absorbent products and allows easy visualization of the skin.• Proven wash-off resistance(15)

• Allows tapes and adhesive to stick to the skin(6)

• Skin friendly—hypoallergenic and pH balanced(6)

• Compatible with chlorhexidine gluconate(6)

• Use of Cavilon No Sting Barrier Film was found to be effective for the treatment and prevention of IAD(7, 13, 14)

• Cavilon Durable Barrier Cream was shown to be significantly more resistant to wash off than a number of common dimethicone-based barrier creams(15)

• In a health economic study that included 981 subjects, Cavilon No Sting Barrier Film was proven to be cost-effective, significantly reducing product cost and nursing time associated with incontinence skin care versus traditional skin care protocols using barrier ointments or creams(7)

3M™ Cavilon™ Skin Care Products: What Does The Evidence Say? • Introduction of Cavilon No Sting Barrier Film and Cavilon Durable Barrier

Cream as part of a comprehensive skin care program was associated with:

- A reduction in the incidence (and severity) of incontinence dermatitis and the incidence of pressure ulcers(8)

- A reduction in the incidence of pressure ulcers(12)

Using Products Wisely

• Reapply every 8–24 hours, depending on the frequency of incontinence

• For incontinence—reapply every 24–72 hours. For patients at higher risk of skin damage (e.g. constant diarrheal stooling) more frequent application may be necessary (every 12 hours)

• For skin protection from adhesive tapes, dressings or devices—reapply each time dressing and/or adhesive product is changed

• For other skin protection needs—reapply as needed

Cavilon No Sting Barrier Film Cavilon Durable Barrier Cream

Choice of 4convenient formats: • 28ml spray* • 3ml foam wand • 1ml foam wipe• 1ml foam wand

Choose Your Skin Protection Product

Catalog No. Product Size Items/

BoxBoxes/Case

3346 3M™ Cavilon™ No Sting Barrier Film 28ml spray* 12 1

3345 3M™ Cavilon™ No Sting Barrier Film 3.0ml wand 25 4

Also available for other indications

3344 3M™ Cavilon™ No Sting Barrier Film 1.0ml wipe 25 4

3343 3M™ Cavilon™ No Sting Barrier Film 1.0ml wand 25 4

3M™ Cavilon™ No Sting Barrier Film

Wipe1ml

Wand1ml

Wand3ml

Spray28ml

*The 28 ml spray is both convenient and economical to use for skin protection in the perineal/sacral area

Catalog No. Product Size Items/

BoxBoxes/Case

3355 3M™ Cavilon™ Durable Barrier Cream 92g tube 12 1

3354 3M™ Cavilon™ Durable Barrier Cream 28g tube 48 1

3353 3M™ Cavilon™ Durable Barrier Cream 2g sachet 20 12

3M™ Cavilon™ Durable Barrier Cream

Tube28g

Tube92g

Sachet2g

Choice of 3 convenient sizes: • 92g tube • 28g tube • 2g sachet

1. Junkin J, Selekoff J. Prevalence of incontinence and associated skin injury in the acute care inpatient. J WOCN. 2007;34(3): 260-269.

2. Peterson KJ, Bliss DZ, Nelson C, Savik K. Practices of nurses and nursing assistants in preventing incontinence associated dermatitis in acutely/critically ill patients. Amer J of Crit Care. (Abstract) 2006;15(3): 325.

3. Ratliff CR, Tomaselli N. Guideline for Prevention and Management of Pressure Ulcers. Wound Ostomy and Continence Nurses Society. 2003.

4. Registered Nurses Association of Ontario (RNAO). Risk assessment & prevention of pressure ulcers. Toronto (ON): Registered Nurses Association of Ontario (RNAO);2005.

5. Zehrer CL, Newman DK, Grove GL, Lutz JB. Assessment of diaper-clogging potential of petrolatum moisture barriers. Ostomy Wound Manage. 2005;51(12): 54-8.

6. 3M data on file.

7. Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence. J WOCN 2007;34(2): 143-52.

8. Bale S, Tebble N, Jones V, Price P. The benefits of implementing a new skin care protocol in nursing homes. J of Tissue Viability. 2004;14(2): 44-50.

9. 3M Health Care. Cavilon No Sting Barrier Film. Clinical Evidence Summaries. 2012.

10. Hart J. Assessment of the incontinence pad blocking potential of 3M Cavilon Durable Barrier Cream compared with sudocrem and zinc & castor oil. Nursing Scotland. July/August 2002.

11. 3M Health Care. Cavilon Durable Barrier Cream. Clinical Evidence Summaries. 2012.

12. Desjarlais-Tefft B. Health care aides: first line of defense in the prevention of skin breakdown. Poster presentation at Ontario Long Term Care Conference. 2010.

13. Baatenburg de Jong H, Admiraal H. Comparing cost per use of 3M™ Cavilon™ No Sting Barrier Film with zinc oxide oil in incontinent patients. J of Wound Care. 2004;13(9): 398-400.

14. Rueda-Lopez J et al. A comparative study of a barrier product versus zinc oxide for the treatment of incontinent lesions. Oral presentation at the World Union Wound Healing Society (WUWHS) Meeting. 2004.

15. Grove G, Houser T, Zerwick C. A comparison of the effectiveness and wash-off resistance of four dimethicone skin barrier creams. Poster resented at the Clinical Symposium on Advances in Skin and Wound Care. 2010.

References:

© 3M 2013. All rights reserved.

70-2010-9198-3

3M and Cavilon are trademarks of 3M Used under license in Canada. Please recycle. Printed in USA.

Critical & Chronic Care Solutions Division3M Health Care2510 Conway AvenueSt. Paul, MN 55144USA1-800-228-3957www.3M.com/Cavilon

3M CanadaP.O. Box 5757London, Ontario N6A 4T1Canada1-800-563-2921www.3m.ca/skinwound